Company / Shares Outstanding
Phathom Pharmaceuticals, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
68.5M
FY2025
5-year range
37.0M / 68.5M
FY2021-FY2025
Trend
+18.2%
vs FY2024
Sector context
#132 of 212
Health Care
What the data says
At 68518238.00, Phathom Pharmaceuticals, Inc.'s shares outstanding ranks #81 of 212 in the Health Care sector. Shares Outstanding has increased for 7 consecutive years, from 6051675.00 in FY2018 to 68518238.00 in FY2025.
Based on SEC 10-K filings.
68518238.00 in FY2025 with a 5-year CAGR of +15.6%.
Increased from 41468871.00 to 68518238.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +20.5%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
#81 of 212 in Health CareTop 38% of 212This company 68.5M Sector average 306.0M
▼
-77.6% below sector average
Key checks
Key Insights
- Phathom Pharmaceuticals, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 18.2% year-over-year.
- Ranks #132 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 68.5M | +18.2% |
| FY2024 | 58.0M | +39.8% |
| FY2023 | 41.5M | +6.0% |
| FY2022 | 39.1M | +5.7% |
| FY2021 | 37.0M | +11.4% |
| FY2020 | 33.2M | +192.3% |
| FY2019 | 11.4M | +87.8% |
| FY2018 | 6.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026